These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 20030422)

  • 21. [Evidence-based recommendations for the treatment of fibromyalgia syndrome].
    Harten P; Genth E
    Z Rheumatol; 2010 Jul; 69(5):457-60. PubMed ID: 18836732
    [No Abstract]   [Full Text] [Related]  

  • 22. Pregabalin: its efficacy, safety and tolerability profile in fibromyalgia syndrome.
    Owen RT
    Drugs Today (Barc); 2007 Dec; 43(12):857-63. PubMed ID: 18174971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fibromyalgia: harmonizing science with clinical practice considerations.
    Perrot S; Dickenson AH; Bennett RM
    Pain Pract; 2008; 8(3):177-89. PubMed ID: 18363616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interference with work in fibromyalgia: effect of treatment with pregabalin and relation to pain response.
    Straube S; Moore RA; Paine J; Derry S; Phillips CJ; Hallier E; McQuay HJ
    BMC Musculoskelet Disord; 2011 Jun; 12():125. PubMed ID: 21639874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibromyalgia: a complex syndrome requiring a multidisciplinary approach.
    Spaeth M; Briley M
    Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S3-10. PubMed ID: 19479907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
    Arnold LM; Leon T; Whalen E; Barrett J
    Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of pregabalin with duloxetine for fibromyalgia: a randomized controlled trial.
    Gilron I; Chaparro LE; Tu D; Holden RR; Milev R; Towheed T; DuMerton-Shore D; Walker S
    Pain; 2016 Jul; 157(7):1532-40. PubMed ID: 26982602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fibromyalgia coverage uneven despite recent drug approvals.
    Sipkoff M
    Manag Care; 2008 Dec; 17(12):9-10. PubMed ID: 19127758
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlations between fibromyalgia symptom and function domains and patient global impression of change: a pooled analysis of three randomized, placebo-controlled trials of pregabalin.
    Arnold LM; Zlateva G; Sadosky A; Emir B; Whalen E
    Pain Med; 2011 Feb; 12(2):260-7. PubMed ID: 21266008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of pain medication selection among patients diagnosed with fibromyalgia.
    Boulanger L; Wu N; Chen SY; Nagar S; Fraser K; Bernauer MJ; Zhao Z; Zhao Y
    Pain Pract; 2012 Apr; 12(4):266-75. PubMed ID: 21899718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibromyalgia: presentation and management with a focus on pharmacological treatment.
    Sumpton JE; Moulin DE
    Pain Res Manag; 2008; 13(6):477-83. PubMed ID: 19225604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drugs to treat fibromyalgia - the transatlantic difference.
    Briley M
    Curr Opin Investig Drugs; 2010 Jan; 11(1):16-8. PubMed ID: 20047155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to: Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: How study designs can affect placebo factors.
    Moore RA; Derry S; McQuay HJ
    Pain; 2008 Oct; 139(2):477-479. PubMed ID: 18790568
    [No Abstract]   [Full Text] [Related]  

  • 34. Long-term trials of pregabalin and duloxetine for fibromyalgia symptoms: how study designs can affect placebo factors.
    Staud R; Price DD
    Pain; 2008 Jun; 136(3):232-234. PubMed ID: 18384959
    [No Abstract]   [Full Text] [Related]  

  • 35. Fibromyalgia syndrome: practical strategies for improving diagnosis and patient outcomes.
    Arnold LM; Clauw DJ
    Am J Med; 2010 Jun; 123(6):S2. PubMed ID: 20569735
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The psychiatrist confronted with a fibromyalgia patient.
    Kasper S
    Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S25-30. PubMed ID: 19479904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy and tolerability of duloxetine, pregabalin, and milnacipran for the treatment of fibromyalgia: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Rheumatol Int; 2016 May; 36(5):663-72. PubMed ID: 27000046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
    Sommer C; Häuser W; Alten R; Petzke F; Späth M; Tölle T; Uçeyler N; Winkelmann A; Winter E; Bär KJ;
    Schmerz; 2012 Jun; 26(3):297-310. PubMed ID: 22760463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of anxiety and depression on improvements in pain in a randomized, controlled trial of pregabalin for treatment of fibromyalgia.
    Arnold LM; Crofford LJ; Martin SA; Young JP; Sharma U
    Pain Med; 2007; 8(8):633-8. PubMed ID: 18028041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregabalin: an alpha2-delta (alpha2-delta) ligand for the management of fibromyalgia.
    Arnold L; Mease P; Silverman S
    Am J Manag Care; 2010 May; 16(5 Suppl):S138-43. PubMed ID: 20586522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.